London – UK health officials begin rolling out the first dose of widely tested and independently reviewed Covid-19 vaccine On Tuesday, a global immune program is launching that is expected to gain momentum to get more serum approval. The first shot came early in the morning in a network of hospital hubs across the country where the initial phase of the UK program will be placed on a dub called “V-Day”.
Public health officials are telling the public to be patient because only those people are at greater risk than the new ones Corona virus Vaccination will be given at an early stage. Medical staff will contact people to make appointments and most people will have to wait until next year before enough vaccines arrive to expand the program.
Jacob King / Pool / AP
Simon Stevens, CEO of the National Health Service of England, said: “I think there is every possibility that we will return … (Tuesday) marked a turning point in the fight against coronavirus.”
The first recipient was grandmother Margaret Keenan, who turns 91 next week. He received a shot at the University H Hospital Spital Cove Ventry at 6:30 p.m.
Keane said he felt “I have the privilege of being the first person to be vaccinated against COVID-19.”
“I wish it’s the best time for an early birthday because it means I can finally look forward to spending most of the year on my own and spending time with my family and friends in the new year,” he said.
The second injection went to 811-year-old William Shakespeare, from Warwickshire, the county where Bard was born, and was asked for a possible response in the online and offline press.
“Flu’s Taming Ming: William Shakespeare became the second person to receive the covid vaccine,” he quoted a British independent newspaper as saying.
In a tweet, he thanked UK Prime Minister Boris Jones for helping the country’s healthcare, vaccine developers, volunteers who helped make the trial safer and more effective, and “everyone who follows the rules to protect others.”
“We’ll beat this together,” Jones said.
The first 800,000 doses of the Pfizer vaccine in the UK are going for more than 80 people, who are either hospitalized or already schedule the appointment of outpatients with nursing home workers. Others will have to wait their turn, but all vaccines will be provided free of charge by Britain’s National Health Service.
It remains to be vaccinated among older Britons, including Hari Shukla of Newcastle.
“When I received the telephone call, I was very excited. I had the opportunity to join and participate in it,” he said. “So we are very happy and happy and excited.”
Buckingham Palace declined to comment on reports that 94-year-old Queen Elizabeth II and her 99-year-old husband Prince Philip would be vaccinated as a public example of her safety.
The chief executive of Britain’s Medicines and Healthcare Products Regulatory Agency, Dr. “Our goal is to fully protect every member of the population, Her Majesty,” June Raine told the BBC.
Elsewhere, public health officials are watching Britain’s rollout as it prepares for an unprecedented task of vaccinating billions to end an epidemic that has killed more than 1.5 million people. While the UK has a well-developed infrastructure to deliver vaccines, but is prepared to operate them in groups such as school children or pregnant women, not the entire population.
On December 2, British regulators announced that the U.S. The UK has launched the project following emergency authorization of a vaccine manufactured by drugmaker Pfizer and Germany’s Bioentech. U.S. And European Union authorities The vaccine is also being reviewed in collaboration with Oxford University and drugmaker AstraZeneca, along with rival products developed by biotechnology company Modern.
On saturday Russia began vaccinating thousands of people Doctors, teachers and others at dozens of centers in Moscow with his Sputnik Vine vaccine. That program is being viewed differently since Russia authorized the use of Sputnik V last summer after testing it in only a few dozen people.
Kirill Kudravyavisite / AFP / Getty
Russia does not yet have significant trial data on elderly patients, and has only made its vaccine available to Moscow residents between the ages of 18 and 60.
The first shipment of the Pfizer-Bioentech vaccine was delivered on Sunday to a select group of UK hospitals.
One of the facilities, Cryden University H Hospital Spital, south of London, staff members could not touch the vials, but they were thrilled to keep them in the building.
“I’m very proud,” said Lewis Kaflan, joint chief pharmacist of the Creedon Health Services NHS Trust.
The vaccine is not readily available in the UK, with more than 1,000 seaweed-related deaths reported in Europe. There are over 1.7 million cases in the UK.
800,000 doses is only a fraction of what is required. The government is targeting more than 25 million people or about 40% of the population in the first phase of its vaccination program, giving first priority to those most at risk from the disease.
After more than 800 years and nursing home workers, the supply-increasing program will be expanded, with approximate vaccinations based on age groups, starting with the oldest.
In England, the vaccine will be delivered to hospital0 hospital hub in the first wave of the program, with more hospitals expected to offer it as a rollout ramp. Northern Ireland, Scotland and Wales are making their own plans under the UK’s distorted administration system.
British officials have made it clear that the vaccine will not be mandatory for anyone. As residents become eligible, they will be notified by their doctor’s office or the National Health Service and urged to make an appointment for inoculation.
Logistic issues are slowing down the delivery of the Pfizer vaccine as it will have to be stored at minus -94 degrees Fahrenheit.
NHS The immunization program will be “not a marathon sprint,” said Professor Stephen Powis, England’s medical director.
Officials are also focusing on large-scale distribution issues as each package of vaccine contains 975 doses and they do not want any to be wasted.
The UK has agreed to buy millions of doses from seven different manufacturers. Governments around the world are entering into agreements with multiple developers to ensure that they lock down the delivery of products that are finally approved for widespread use.
.
